India vildagliptin market is
expected to grow at a steady rate during the forecast period, owing to the increasing
diabetic population in the country. Additionally, supportive government
policies and improving healthcare infrastructure are also expected to create
lucrative opportunities for the market growth over the next few years.
Furthermore, initiatives taken by physicians to minimize the costly burden of
diabetic complications using combination therapies and novel branded drugs are
further expected to rev up the market growth through FY2026.
The India vildagliptin market is
segmented based on composition, source, strength, distribution channel,
application, company and region. Based on source, the market can be split into
in-house and contract manufacturing organizations. Out of which, the in-house
segment dominated the market until FY2020 owing to in-house production
preference by the major market players. The contract manufacturing
organizations segment is expected to witness significant growth during the
forecast period on account of an upsurge in the number of contract
manufacturers in the country and increased outsourcing activities by the major
companies in order to focus on their R&D activity and expansion plans.
Additionally, contract manufacturing organizations offer competitive pricing
and can provide bulk orders in a short duration. This is further projected to
contribute to the segmental growth in the coming years.
The major players operating in the
India vildagliptin market are Abbott India Limited, Torrent Pharmaceuticals
Limited, Intas Pharmaceuticals Limited, Dr. Reddy’s Laboratories Ltd., IPCA
Laboratories Ltd., Lupin Limited, Piramal Enterprises Ltd. (Piramal Pharma), Novartis
India Limited, Cipla Ltd., Alembic Pharmaceuticals Ltd and others. Major
companies are developing advanced technologies, receiving approvals from regulatory
bodies and launching new products in order to stay competitive in the market.
Other competitive strategies include mergers and acquisitions and new product
developments.
Years considered for this report:
Historical Years: FY2016-FY2019
Base Year: FY2020
Estimated Year: FY2021
Forecast Period: FY2022–FY2026
Objective of the Study:
- To analyze the historical growth in the market size of India vildagliptin
market from FY2016 to FY2020.
- To estimate and forecast the market size of India vildagliptin market
from FY2021 to FY2026 and growth rate until FY2026.
- To classify and forecast India vildagliptin market based on composition,
source, strength, distribution channel, application, company and regional
distribution.
- To identify dominant region or segment in the India vildagliptin market.
- To identify drivers and challenges for the India vildagliptin market.
- To examine competitive developments such as expansions, new product
launches, and mergers & acquisitions in India vildagliptin market.
- To identify and analyze the profile of leading players operating in
the India vildagliptin market.
- To identify key sustainable strategies adopted by market players in
the India vildagliptin market.
Click here to download the sample
TechSci Research performed both primary
as well as exhaustive secondary research for this study. Initially, TechSci
Research sourced a list of manufacturers across the globe. Subsequently,
TechSci Research conducted primary research surveys with the identified
companies. While interviewing, the respondents were also enquired about their
competitors. Through this technique, TechSci Research could include the
manufacturers which could not be identified due to the limitations of secondary
research. TechSci Research analyzed the manufacturers, distribution channels
and presence of all major players across the globe.
TechSci
Research calculated the market size of India vildagliptin market using a bottom-up approach, wherein data for various end-user
segments was recorded and forecast for the future years. TechSci Research
sourced these values from the industry experts and company representatives and
externally validated through analyzing historical data of these product types
and applications for getting an appropriate, overall market size. Various
secondary sources such as company websites, news articles, press releases,
company annual reports, investor presentations and financial reports were also
studied by TechSci Research.
Key Target Audience:
- Vildagliptin manufacturers/ suppliers/
distributors
- Market research and consulting firms
- Government bodies such as regulating
authorities and policy makers
- Organizations, forums and alliances related to
vildagliptin
The study is useful in providing answers to several critical
questions that are important for the industry stakeholders such as
manufacturers, suppliers and partners, end users, etc., besides allowing them
in strategizing investments and capitalizing on market opportunities.
Report Scope:
In this report,
India vildagliptin market has been segmented into the following
categories, in addition to the industry trends that have also been detailed
below:
- India Vildagliptin Market, By Composition:
- India Vildagliptin Market, By Source:
- In-house
- Contract
Manufacturing Organizations
- India Vildagliptin Market, By Strength:
- India Vildagliptin Market, By Distribution Channel:
- India Vildagliptin Market, By Application:
- Type 2
Diabetes Mellitus
- Hyperglycaemia
- India Vildagliptin Market, By Region:
Competitive Landscape
Company Profiles: Detailed analysis of the major
companies present in India vildagliptin market.
Available Customizations:
With the given market data, TechSci Research offers
customizations according to a company’s specific needs. The following
customization options are available for the report:
Company Information
- Detailed analysis and
profiling of additional market players (up to five).
India vildagliptin market
is an upcoming report to be released soon. If you wish an early delivery of
this report or want to confirm the date of release, please contact us at [email protected]